Company intelligence / Profile preview

Daepyung

Hamchang-eup/Sangju-si, Gyeongsangbuk-do, South Koreadaepyung.co.kr ↗

Ownership: Private
Employees: ~51
Development stage: Commercial

Overview

Daepyung leads the Korean market in stevia-based sweeteners and supplies a range of natural food additives, cosmetic ingredients such as licorice extract with anti-inflammatory properties, and pharmaceutical raw materials. The company has an active R&D program focused on developing new high-value-added natural substances using advanced separation/refining technology. It operates globally with a strong presence in Asia and Europe.

Therapeutic areas: Other
Modalities: Small molecule (natural extracts)Biologic (probiotics, nutritional yeasts)Protein (enzymes from natural sources)Peptides (from herbal/natural extracts)Nutritional supplement ingredient
Industry: Food & Nutrition

Partnerships

Not specifically listed; global distribution partners mentioned

Beyond the preview

Go deeper on Daepyung.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Daepyung.

Explore the full profile